Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Tyra Bioscience (TYRA) Drug Pipeline

159 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Dabogratinib 60Mg, Dabogratinib 80Mg, Dabogratinib TbdLow Grade Upper Tract Urothelial CarcinomaPhase IIRecruitingPhase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial CarcinomaNov 19, 2025
Tyra-300 60Mg, Tyra-300 50Mg, Tyra-300 Dose TbdFgfr3 Gene Mutation, Fgfr3 Gene Fusions, Fgfr Gene Alterations, Fgfr3 Gene Alteration, Low-Grade Nmibc, Fgfr Gene AmplificationPhase IIRecruitingEfficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder CancerApr 25, 2025
Tyra-430Fgfr Gene Amplification, Fgfr Gene Alterations, Metastatic Hepatocellular Carcinoma, Solid Tumors, Advanced Solid Tumors, Solid Tumor, Adult, Fgfr3 Gene Alteration, Fgfr3 Gene Mutation, Fgfr3 Gene Fusions, Fgfr4 Gene Mutation, Fgfr4 Gene Fusions, Fgf19 Gene Amplification, Fgf19 Gene Overexpression, Locally Advanced Unresectable Hepatocellular CarcinomaPhase IRecruitingSafety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway AberrationsMar 31, 2025―
Tyra-300 0.125 Mg/Kg, Tyra-300 0.25 Mg/Kg, Tyra-300 0.375 Mg/Kg, Tyra-300 0.50 Mg/KgAchondroplasiaPhase IIRecruitingA Study of TYRA-300 in Children With Achondroplasia: BEACH301Jan 29, 2025
Phase 1 Part A - Dose Escalation Tyra-200 Taken Once Daily By Mouth In 28-Day Cycles, Phase 1 Part B - Dose Expansion Tyra-200 Taken Once Daily By Mouth In 28-Day CyclesIntrahepatic Cholangiocarcinoma, Metastatic Cholangiocarcinoma, Locally Advanced Cholangiocarcinoma, Solid TumorPhase IRecruitingSafety and Anti-Tumor Activity of TYRA-200 in Advanced Cholangiocarcinoma With Activating FGFR2 Gene AlterationsNov 29, 2023―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Tyra Bioscience, Inc (TYRA) have in its pipeline
Tyra Bioscience TYRA is currently developing the following drugs: Dabogratinib 60Mg, Dabogratinib 80Mg, Dabogratinib Tbd, Tyra-300 60Mg, Tyra-300 50Mg, Tyra-300 Dose Tbd, Tyra-430, Tyra-300 0.125 Mg/Kg, Tyra-300 0.25 Mg/Kg, Tyra-300 0.375 Mg/Kg, Tyra-300 0.50 Mg/Kg, Phase 1 Part A - Dose Escalation Tyra-200 Taken Once Daily By Mouth In 28-Day Cycles, Phase 1 Part B - Dose Expansion Tyra-200 Taken Once Daily By Mouth In 28-Day Cycles. These drug candidates are in various stages of clinical development as the company works toward FDA approval.